Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
bemarituzumab
×
Clear all
Filters
3
NCT05052801
2026-02-19
FORTITUDE-101
Amgen
Phase 3
Active not recruiting
547 enrolled
NCT05111626
2025-12-15
FORTITUDE-102
Amgen
Phase 3
Active not recruiting
515 enrolled